Showing results (151-160 of 268) with videos related to
Sort By:
Pageof 27
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1984
[Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia]B Vernet-der-Garabédian, E Morel, J F BachThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidemG Perrault, E Morel, D J Sanger, et al.Neuropharmacology|September 1, 1993
Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependenceG Perrault, E Morel, D J Sanger, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|April 19, 2002
Alterations of the VIP-stimulated cAMP pathway in rat distal colon after abdominal irradiationE Morel, I Dublineau, F Lebrun, et al.European Journal of Pharmacology|June 11, 1997
Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6N D'hahan, K Taouil, A Dassouli, et al.Biochemistry|October 22, 1985
Rabbit skeletal myosin heads in solution, as observed by ultracentrifugation and freeze-fracture electron microscopy: dimerization and maximum chordN Bachouchi, A Gulik, M Garrigos, et al.Toxicology|March 1, 1979
Effects of PR toxin on liver cells in cultureC Aujard, E Morel-Chany, C Icard, et al.Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
Comparative study of a novel application of automated HR HPV assay and stability in a previously untested Preservative mediaMike E Morel, Simon E McBride, Maria P GomezBulletin Du Cancer|January 1, 1980
Cytostatic effects of T2 toxin on cultured human neoplastic cells of intestinal originE Morel-Chany, P Burtin, G Trincal, et al.Journal of Neuroimmunology|July 1, 1986
Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravisB Vernet-der Garabedian, E Morel, J F BachPageof 27